FDA Alerts

Drug Therapy
Drug Therapy
FDA Approves First Pill With Ingestion Tracking System
11/14/2017
The US Food and Drug Administration recently approved the first pill with an embedded digital ingestion tracking system for patients with schizophrenia, bipolar disorder, and depression.
11/14/2017
FDA
FDA
FDA Approves New Maintenance Treatment for Schizophrenia
11/13/2017
The US Food and Drug Administration has approved a once-daily oral antipsychotic for the maintenance treatment of schizophrenia.
11/13/2017
FDA
FDA
FDA: New Vaccine Approved for Hepatitis B
11/13/2017
The US Food and Drug Administration has approved the first new vaccine for hepatitis B virus in over 25 years in the United States.
11/13/2017
venous thromboembolism
venous thromboembolism
FDA Approves New Dose for VTE Drug
11/01/2017
The US Food and Drug Administration recently approved a new dosing option for patients receiving treatment for recurrent venous thromboembolism.
11/01/2017
FDA Alerts
FDA Alerts
FDA Approves New Option for Generalized Myasthenia Gravis
10/25/2017
The US Food and Drug Administration has expanded the approval of a drug to include patients with generalized myasthenia gravis.
10/25/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves Once-Weekly Diabetes Option
10/23/2017
The FDA has approved a new once-weekly, extended-release option for the treatment of adults with type 2 diabetes and uncontrolled blood sugar levels.
10/23/2017
Herpes Zoster
Herpes Zoster
FDA Approves New Herpes Zoster Vaccine
10/23/2017
Based on the results of a clinical trial program, the FDA has approved a new option for the prevention of herpes zoster.
10/23/2017
Drug Therapy
Drug Therapy
FDA: New Indications For Simponi Aria Approved
10/23/2017
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved Simponi Aria for 2 new indications in adult patients.
10/23/2017
neuropathy
neuropathy
FDA Approves Extended-Release Tablets for Neuropathic Pain
10/12/2017
The US Food and Drug Administration recently approved once-daily extended-release tablets for the management of 2 peripheral neuropathic pain conditions.
10/12/2017
Knee pain
Knee pain
FDA Approves Extended-Release Intra-Articular Injection
10/10/2017
After results from a clinical trial demonstrated its safety and efficacy, the US Food and Drug Administration recently approved the first and only extended-release intra-articular injection for patients...
10/10/2017